146 related articles for article (PubMed ID: 1383625)
81. Analysis of increased myocardial contractility during sodium acetate infusion in humans.
Nitenberg A; Huyghebaert MF; Blanchet F; Amiel C
Kidney Int; 1984 Nov; 26(5):744-51. PubMed ID: 6521259
[TBL] [Abstract][Full Text] [Related]
82. The metabolical effects of L-carnitine in angina pectoris.
Ferrari R; Cucchini F; Visioli O
Int J Cardiol; 1984 Feb; 5(2):213-6. PubMed ID: 6698646
[TBL] [Abstract][Full Text] [Related]
83. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
Brevetti G; Perna S; Sabbà C; Rossini A; Scotto di Uccio V; Berardi E; Godi L
Eur Heart J; 1992 Feb; 13(2):251-5. PubMed ID: 1555624
[TBL] [Abstract][Full Text] [Related]
84. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction.
Jeejeebhoy F; Keith M; Freeman M; Barr A; McCall M; Kurian R; Mazer D; Errett L
Am Heart J; 2002 Jun; 143(6):1092-100. PubMed ID: 12075268
[TBL] [Abstract][Full Text] [Related]
85. Efficacy of L-propionylcarnitine treatment in patients with left ventricular dysfunction.
Caponnetto S; Canale C; Masperone MA; Terracchini V; Valentini G; Brunelli C
Eur Heart J; 1994 Sep; 15(9):1267-73. PubMed ID: 7982429
[TBL] [Abstract][Full Text] [Related]
86. [Effect of isoptin on myocardial hemodynamics and contractility during an anginal attack induced by the atrial stimulation test].
Vakhliaev VD; Pomerantsev EV; Serova IV; Petriĭ VV; Iudichev IS
Kardiologiia; 1985 Aug; 25(8):22-5. PubMed ID: 4068454
[TBL] [Abstract][Full Text] [Related]
87. Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.
Yamada KA; Dobmeyer DJ; Kanter EM; Priori SG; Corr PB
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():67-76. PubMed ID: 2031873
[TBL] [Abstract][Full Text] [Related]
88. The effects of coronary artery disease on cardiac function in nonhypotensive sepsis.
Raper RF; Sibbald WJ
Chest; 1988 Sep; 94(3):507-11. PubMed ID: 3409729
[TBL] [Abstract][Full Text] [Related]
89. [Effects of levocarnitine chloride (LC-80) on hemodynamics and myocardial metabolism in anesthetized open-chest dogs under normoxic or hypoxic conditions].
Kirimoto T; Ohtani K; Yamada H; Fujisawa S; Hironaka Y
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):119-31. PubMed ID: 2731804
[TBL] [Abstract][Full Text] [Related]
90. Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study.
Sabbá C; Berardi E; Antonica G; Ferraioli G; Buonamico P; Godi L; Brevetti G; Albano O
Eur Heart J; 1994 Oct; 15(10):1348-52. PubMed ID: 7821310
[TBL] [Abstract][Full Text] [Related]
91. Correlation between long-chain acylcarnitine in serum and myocardium after heart transplantation in humans.
Olbrich HG; Evangeliou A; Tabatabaei SB; Cieslinski G; Hartmann A; Beyersdorf F; Hermann G; Böhles H
Am J Clin Nutr; 1994 Sep; 60(3):414-7. PubMed ID: 8074075
[TBL] [Abstract][Full Text] [Related]
92. Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris.
Bergman G; Atkinson L; Metcalfe J; Jackson N; Jewitt DE
Eur Heart J; 1980 Aug; 1(4):247-53. PubMed ID: 7274235
[No Abstract] [Full Text] [Related]
93. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction.
Singh RB; Niaz MA; Agarwal P; Beegum R; Rastogi SS; Sachan DS
Postgrad Med J; 1996 Jan; 72(843):45-50. PubMed ID: 8746285
[TBL] [Abstract][Full Text] [Related]
94. Cardiovascular effects of a new inotropic agent, denopamine (TA-064); with reference to it's effects on cardiac hemodynamics and metabolism.
Kino M; Hirota Y; Saitoh T; Nakayama A; Hara M; Sawada K; Yamamoto S; Suwa M; Kubo S; Kawamura K
Jpn Circ J; 1986 Jul; 50(7):644-51. PubMed ID: 3773230
[TBL] [Abstract][Full Text] [Related]
95. The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidaemia.
Böhles H; Lehnert W
Eur J Pediatr; 1984 Nov; 143(1):61-3. PubMed ID: 6510434
[TBL] [Abstract][Full Text] [Related]
96. Properties of carnitine incorporation in working swine hearts. Effects of coronary flow, ischemia, and excess fatty acids.
Liedtke AJ; Vary TC; Nellis SH; Fultz CW
Circ Res; 1982 Jun; 50(6):767-74. PubMed ID: 7083480
[No Abstract] [Full Text] [Related]
97. Effect of intravenous digitoxin on inotropy, haemodynamics and P-Q interval in ischaemic heart disease.
Amlie JP; Sire S; Nitter-Hauge S
Scand J Clin Lab Invest; 1984 Oct; 44(6):503-8. PubMed ID: 6484488
[TBL] [Abstract][Full Text] [Related]
98. The role of carnitine in myocardial dysfunction.
Pauly DF; Pepine CJ
Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S35-43. PubMed ID: 12751052
[TBL] [Abstract][Full Text] [Related]
99. [Effect of rapid digitalization on the left-ventricular myocardial function according to the echocardiographic data].
Belenkov IuN; At'kov OIu; Tsibekmakher TD
Kardiologiia; 1977 Sep; 17(9):46-50. PubMed ID: 926600
[TBL] [Abstract][Full Text] [Related]
100. The protective effect of carnitine in human diphtheric myocarditis.
Ramos AC; Elias PR; Barrucand L; Da Silva JA
Pediatr Res; 1984 Sep; 18(9):815-9. PubMed ID: 6483504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
